Newsroom :: CytoDyn Inc. (CYDY)

For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar

Learn More

CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease

Jun 11, 2026 8:30am EDT

Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer

Jun 04, 2026 8:00am EDT

CytoDyn to Present at the LD Micro Invitational XVI

May 15, 2026 8:30am EDT

CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer

Apr 27, 2026 8:30am EDT

CytoDyn to Host Investor Webcast

Apr 23, 2026 8:30am EDT

CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026

Apr 22, 2026 8:30am EDT

CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study

Apr 21, 2026 4:10pm EDT

CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026

Apr 20, 2026 8:30am EDT

CytoDyn to Present at the AACR Annual Meeting 2026

Apr 14, 2026 8:30am EDT

CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer

Mar 24, 2026 8:30am EDT

1
2
3
4
5
6
7
8